Investing

Schrodinger : SDGR

SDGR

Stock Data

$12.39

$0.43 (3.60%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

HEALTH INFORMATION SERVICES

Schrodinger Inc is a pioneer in developing a computational platform designed to accelerate the discovery of novel molecules for both drug development and materials applications. With a focus on licensing its groundbreaking software, the company supports the life sciences and materials science industries in transforming molecular discovery. Additionally, Schrodinger is actively involved in drug discovery, working on a portfolio of preclinical and clinical programs on its own and through partnerships. Founded in 1990 and headquartered in New York, it serves a global clientele including biopharmaceutical companies, academic institutions, and government labs.

All Schrodinger Articles

1 Article

Eric Bleeker | Jun 1, 2024 at 1:08 PM EDT

1 Growth Stock That Could Dominate AI’s Next Breakthrough

This discussion explores secondary opportunities to benefit from the AI boom beyond the most talked about stocks like NVIDIA (NASDAQ:…